These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 16827763)

  • 1. Cost-effectiveness analysis of levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Brown PM; Farquhar CM; Lethaby A; Sadler LC; Johnson NP
    BJOG; 2006 Jul; 113(7):797-803. PubMed ID: 16827763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N
    BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
    Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States.
    Ganz ML; Shah D; Gidwani R; Filonenko A; Su W; Pocoski J; Law A
    Value Health; 2013; 16(2):325-33. PubMed ID: 23538185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized prospective trial comparing the levonorgestrel-releasing intrauterine system with thermal balloon ablation for the treatment of heavy menstrual bleeding.
    de Souza SS; Camargos AF; de Rezende CP; Pereira FA; Araújo CA; Silva Filho AL
    Contraception; 2010 Mar; 81(3):226-31. PubMed ID: 20159179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
    de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
    Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding: a cost-effectiveness analysis.
    van den Brink MJ; Beelen P; Herman MC; Geomini PM; Dekker JH; Vermeulen KM; Bongers MY; Berger MY
    BJOG; 2021 Nov; 128(12):2003-2011. PubMed ID: 34245652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
    Reid PC; Virtanen-Kari S
    BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain.
    Calaf J; Lete I; Canals I; Crespo C; Espinós B; Cristóbal I
    Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():24-31. PubMed ID: 25462215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.
    Gupta JK; Daniels JP; Middleton LJ; Pattison HM; Prileszky G; Roberts TE; Sanghera S; Barton P; Gray R; Kai J;
    Health Technol Assess; 2015 Oct; 19(88):i-xxv, 1-118. PubMed ID: 26507206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women.
    Milsom I
    Contraception; 2007 Jun; 75(6 Suppl):S152-4. PubMed ID: 17531608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of menorrhagia with an LNG-IUS.
    Pakarinen P; Luukkainen T
    Contraception; 2007 Jun; 75(6 Suppl):S118-22. PubMed ID: 17531601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
    Andrade A; Wildemeersch D
    Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
    Lukes AS; Reardon B; Arepally G
    Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing drug-resistant essential menorrhagia without hysterectomy.
    Hurskainen R
    Best Pract Res Clin Obstet Gynaecol; 2006 Oct; 20(5):681-94. PubMed ID: 16731045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year follow-up of levonorgestrel-releasing intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: a randomized controlled trial.
    Silva-Filho AL; Pereira Fde A; de Souza SS; Loures LF; Rocha AP; Valadares CN; Carneiro MM; Tavares RL; Camargos AF
    Contraception; 2013 Apr; 87(4):409-15. PubMed ID: 23228505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of quality of life and cost-effectiveness of definitive surgery and the levonorgestrel intrauterine system as treatment options for heavy menstrual bleeding.
    Adigüzel C; Seyfettinoğlu S; Aka Satar D; Arlier S; Eskimez E; Kaya F; Nazik H
    Turk J Med Sci; 2017 Jun; 47(3):789-794. PubMed ID: 28618723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.